Subdural space

New Research Shows Minimally Invasive Therapy (Middle Meningeal Artery Embolization) is Effective in Treating Chronic Subdural Hematoma

Retrieved on: 
Monday, February 12, 2024
Subdural space, Recurrence, Doctor of Philosophy, Neurosurgery, Blood, Arm, STEM, FDA, U.S. FDA, Skull, Leg, BALT, Society, University, Disease, Stony Brook University, MMAE, Patient, MPH, Epidural hematoma, Mortality, Research, Brain, Birth control

FAIRFAX, Va., Feb. 12, 2024 /PRNewswire/ -- The Society of Neurolnterventional Surgery (SNIS) is acknowledging middle meningeal artery embolization (MMAE) as a beneficial adjunctive treatment for chronic subdural hematoma in light of new research. The minimally invasive MMAE procedure significantly reduced the failure rates of traditional surgical and non-surgical management strategies without an increased rate of serious neurological complications.

Key Points: 
  • Chronic subdural hematoma refers to the gradual accumulation of blood over the surface of the brain.
  • As the U.S. population continues to age, studies show that chronic subdural hematomas may be the most prevalent neurosurgical diagnosis that requires treatment within the next decade.
  • However, an average of 10% to 30% of patients experience recurrence of chronic subdural hematoma after surgery, often necessitating reoperation.
  • Chronic subdural hematoma is an exceedingly common problem, and these findings will be relevant to a large population of patients.